Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14-day Concomitant Therapy for H. pylori
NCT04991584Unknown
- Sponsor
- Shandong University
- Start
- Aug 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of furazolidone in Helicobacter pylori infection, sponsored by Shandong University. Primary endpoint: Eradication rates at 6 months. Status: unknown.
02
Drugs
furazolidone
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04991584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04991584.